Skip to Main Content

Author Details

Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
1997
116
41
PMIDPaper TitleJournal TitlePublished Year
38079590Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?J Clin Oncol2024
34653954Impact of COVID-19 on presentation, staging, and treatment of head and neck mucosal squamous cell carcinoma.Am J Otolaryngol2022
35504501The Use of Low-Dose Radiation Therapy in Osteoarthritis: A Review.Int J Radiat Oncol Biol Phys2022
35595157Noninvasive Capsulotomy for Refractory Depression by Frameless Stereotactic Radiosurgery.Int J Radiat Oncol Biol Phys2022
35483066Validity Testing of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.Lymphat Res Biol2022
35125231In reply to: Impact of COVID-19 on head and neck mucosal squamous cell carcinoma: Correspondence.Am J Otolaryngol2022
35150023Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.Head Neck2022
35276673NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.J Natl Compr Canc Netw2022
34454047Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.Int J Radiat Oncol Biol Phys2022
32660391Contemporary Management of Jugular Paragangliomas With Neural Preservation.Otolaryngol Head Neck Surg2021
34631230Effects of cone versus multi-leaf collimation on dosimetry and neurotoxicity in patients with small arteriovenous malformations treated by stereotactic radiosurgery.J Radiosurg SBRT2021
34715657Targeting for stereotactic radiosurgical thalamotomy based on tremor treatment response.J Neurosurg2021
34043410Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?J Clin Oncol2021
34149025Diameter-Based Volumetric Models May Inadequately Calculate Jugular Paraganglioma Volume Following Sub-Total Resection.Otol Neurotol2021
34306917Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Nonfunctioning Pituitary Adenoma.J Neurol Surg B Skull Base2021
34306912Progressive Vestibular Schwannoma following Subtotal or Near-Total Resection: Dose-Escalated versus Standard-Dose Salvage Stereotactic Radiosurgery.J Neurol Surg B Skull Base2021
33068688Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.Int J Radiat Oncol Biol Phys2021
33122499Chronic Electroconvulsive Therapy May Induce Calvarial Hyperemia and Marrow Replacement.J ECT2021
33229880Transient Subacute Facial Nerve Dysfunction After Dual Modality Treatment of Large Vestibular Schwannomas.Otol Neurotol2021
32271262Radiotherapy and Radiosurgery for Treatment of Residual or Recurrent Endolymphatic Sac Tumor Following Previous Microsurgical Resection.Otol Neurotol2020
31789966Long-term Outcomes for the Treatment of Paragangliomas in the Upfront, Adjuvant, and Salvage Settings With Stereotactic Radiosurgery and Intensity-modulated Radiotherapy.Otol Neurotol2020
31789797Current Volumetric Models Overestimate Vestibular Schwannoma Size Following Stereotactic Radiosurgery.Otol Neurotol2020
33353553ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck Cancer.Cancers Head Neck2020
32717053Improved Cerebral Arteriovenous Malformation Obliteration With 3-Dimensional Rotational Digital Subtraction Angiography for Radiosurgical Planning: A Retrospective Cohort Study.Neurosurgery2020
32634781Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2020
32770612Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.Head Neck2020
32185088Secondary malignancy following stereotactic radiosurgery for benign neurologic disease: A cohort study and review of the literature.J Radiosurg SBRT2020
32185084Body mass index and response to stereotactic radiosurgery in the treatment of refractory trigeminal neuralgia: A retrospective cohort study.J Radiosurg SBRT2020
32500007Longitudinal Radiographic Outcomes of Vestibular Schwannoma in Single and Fractionated Stereotactic Radiosurgery: A Retrospective Cohort Study.J Neurol Surg B Skull Base2020
31552580Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing's disease.Pituitary2019
31215628A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.Neurosurgery2019
31529045In Reply: A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.Neurosurgery2019
29411506A simple technique to improve calculated skin dose accuracy in a commercial treatment planning system.J Appl Clin Med Phys2018
30241193Evolving Treatment Paradigms for Oropharyngeal Squamous Cell Carcinoma.J Glob Oncol2018
29752322NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.J Natl Compr Canc Netw2018
28029303E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.J Clin Oncol2017
28488066A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases.J Neurooncol2017
28086954A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.Radiat Oncol2017
28430530Reply to A. Garden et al.J Clin Oncol2017
28430529Purpose of Induction Chemotherapy in E1308 and Importance of Patient-Reported Outcomes in Deintensification Trials.J Clin Oncol2017
29218301Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.Front Oncol2017
28596256NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.J Natl Compr Canc Netw2017
28656127Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases.Cureus2017
27720703Margin of error for a frameless image guided radiosurgery system: Direct confirmation based on posttreatment MRI scans.Pract Radiat Oncol2017
26944270Radiotherapy-induced hemichorea.Neurology2016
27305456A Prospective Study of the Lymphedema and Fibrosis Continuum in Patients with Head and Neck Cancer.Lymphat Res Biol2016
27178519Initial radiographic tumor control is similar following single or multi-fractionated stereotactic radiosurgery for jugular paragangliomas.Am J Otolaryngol2016
27419843Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).Cancer2016
27227341Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer Patients.J Palliat Med2016
26705063A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.Oral Oncol2016
  • 1 - 50 of 116

Recommended Authors

University of California San Francisco
Career Start Year 2017
Number of shared co-authors 2
Medical College of Wisconsin
Career Start Year 2013
Number of shared co-authors 3
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 3
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 6
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 12
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 7
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 4
Stanford University
Career Start Year 1999
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 8
Maastricht University Medical Centre
Career Start Year 1999
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 8
University of California san francisco
Career Start Year 1998
Number of shared co-authors 0
Sutter Medical Center Sacramento
Career Start Year 1998
Number of shared co-authors 9
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 1
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 6
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 2
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 7
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 1
University of Antwerp
Career Start Year 1987
Number of shared co-authors 1
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 6
Radboud University Medical Center
Career Start Year 1987
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 1
Duke University Medical Center
Career Start Year 1978
Number of shared co-authors 0

Collaborators

University of Texas MD Anderson Cancer Center
Co-authored papers 19
Vanderbilt University Medical Center
Co-authored papers 18
Vanderbilt University Medical Center
Co-authored papers 16
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 11
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Vanderbilt University School of Medicine
Co-authored papers 10
Vanderbilt University School of Nursing
Co-authored papers 10
University of North Carolina at Chapel Hill
Co-authored papers 9
University of Colorado School of Medicine
Co-authored papers 6
Spanish National Cancer Research Center (CNIO)
Co-authored papers 6
Mayo Clinic
Co-authored papers 5
College of Human Ecology, Cornell University
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 5
Co-authored papers 4
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Co-authored papers 4
Lineberger Cancer Center, University of North Carolina
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
HudsonAlpha Institute for Biotechnology
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
University of Louisville
Co-authored papers 3
University of Louisville
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Medical Center, University of Freiburg
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 1
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 1